Recent advances in cancer diagnostics

Lung cancer is the third most common cancer in the UK, after breast and prostate cancer, and is responsible for over 35,000 deaths per year. Over the past decade, huge strides have been made in terms of survival and because of the burden of this disease the need for improved diagnostics and access to therapies is greater than ever to optimise the quality of life for lung cancer patients.

This story is Premium Content and is only available to registered users. If you don't already have an account, please register with us completely free of charge.

Other news

Upcoming Events


Technological University Dublin
3-4 September 2019

The Oxford Haematology in Obstetrics Postgraduate Course

St Edmund Hall, Queen's Lane, Oxford OX1 4AR
9-11 September 2019

IBMS Biomedical Science Congress

ICC, Birmingham
22-25 September 2019

Lab Innovations

NEC, Birmingham (Hall 12)
30 & 31 October 2019

Latest Issue

Pathology In Practice

Pathology In Practice

Aug 2019

Meet Epredia: introducing a team you already know

Register now to apply for regular copies of Pathology In Practice and free access to premium content, as well as our regular newsletters.